HARTLEV DNA MANAGEMENT ApS: Financial statements 2022
CVR: 36434287
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HARTLEV DNA MANAGEMENT ApS (CVR 36434287) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK 1,423 compared with DKK -77,119 the year before. Equity in the 2022 report amounted to DKK 927,896. The solvency ratio was 99.7%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 1,423
- Equity
- DKK 927,896
- Total Assets
- DKK 930,396
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 0 | 1K | 928K | 0 |
| 2021 | - | 0 | -77K | 926K | 0 |
| 2020 | - | 0 | 298K | 1M | 0 |
| 2019 | - | 0 | 343K | 706K | 0 |
| 2018 | - | 0 | 140K | 363K | 0 |
Official annual report
Keep an eye on HARTLEV DNA MANAGEMENT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HARTLEV DNA MANAGEMENT ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK -77,119.
About HARTLEV DNA MANAGEMENT ApS
HARTLEV DNA MANAGEMENT ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Per Hartlev. The company is owned by Per Hartlev. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,816 and a net result of DKK -22,571 compared with DKK -365,202 the year before. Equity in the 2025 report amounted to DKK 655,345.